Warning: This security is no longer trading.
Sanofi completes acquisition of Synthorx, Inc.
Synthorx, Inc. (THOR): Price and Financial Metrics
THOR Price/Volume Stats
| Current price | $67.99 | 52-week high | $71.90 |
| Prev. close | $67.99 | 52-week low | $11.05 |
| Day low | $67.99 | Volume | 698,100 |
| Day high | $68.01 | Avg. volume | 474,507 |
| 50-day MA | $48.43 | Dividend yield | N/A |
| 200-day MA | $23.82 | Market Cap | 2.20B |
THOR Stock Price Chart Interactive Chart >
Synthorx, Inc. (THOR) Company Bio
Synthorx, Inc. is a biopharmaceutical company, which focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, CA.
THOR Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 301.83% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | 302.13% |
Loading social stream, please wait...